Company / Cash per Share
ORAMED PHARMACEUTICALS INC. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.15
FY2025
5-year range
$0.23 / $1.15
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +403% YoY in FY2025, a notable deviation from the 7-year average annual change of +100%.
Based on SEC 10-K filings.
1.15 in FY2025 with a 5-year CAGR of +43.1%.
Improved from $0.82 to $1.15 over the past 4 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +43.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.15 | - |
| FY2024 | - | - |
| FY2023 | $0.23 | - |
| FY2022 | - | - |
| FY2021 | $0.82 | +325.6% |
| FY2020 | $0.19 | -33.4% |
| FY2019 | $0.29 | +0.6% |
| FY2018 | $0.29 | +17.3% |
| FY2017 | $0.24 | +59.9% |
| FY2016 | $0.15 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026